Androgens Alter Corticotropin Releasing Hormone and Arginine Vasopressin mRNA Within Forebrain Sites Known to Regulate Activity in the Hypothalamic-Pituitary-Adrenal Axis

• Published in: Journal of neuroendocrinology 2001-05, Vol.13 (5), p.442-452
• Main Authors: Viau, V., Soriano, L., Dallman, M. F.
• Format: Article
• Language: English
• Subjects: amygdala; Amygdala - drug effects; Amygdala - physiology; Animals; arginine vasopressin (AVP); Arginine Vasopressin - genetics; bed nuclei of the stria terminalis (BNST); Body Weight - drug effects; corticotropin releasing hormone (CRH); Corticotropin-Releasing Hormone - genetics; Gene Expression - drug effects; Gonadal Steroid Hormones - pharmacology; Hypothalamo-Hypophyseal System - drug effects; Hypothalamo-Hypophyseal System - physiology; Male; Orchiectomy; Paraventricular Hypothalamic Nucleus - drug effects; Paraventricular Hypothalamic Nucleus - physiology; paraventricular nucleus; Pituitary-Adrenal System - drug effects; Pituitary-Adrenal System - physiology; Rats; Rats, Sprague-Dawley; RNA, Messenger - metabolism; Septal Nuclei - drug effects; Septal Nuclei - physiology; testosterone; Testosterone - pharmacology
• ISSN: 0953-8194; 1365-2826
• DOI: 10.1046/j.1365-2826.2001.00653.x

To reveal direct effects of androgens, independent of glucocorticoids, we studied the effects of gonadectomy (GDX) in adrenalectomized (ADX) rats with or without androgen replacement on corticotropin releasing hormone (CRH) and arginine vasopressin (AVP) mRNA expression within various forebrain sites known to regulate the hypothalamic‐pituitary‐adrenal axis. These included the medial parvocellular portion of the paraventricular nucleus of the hypothalamus (mp PVN), the central and medial nuclei of the amygdala and bed nuclei of the stria terminalis (BNST). In the mp PVN, ADX stimulated both CRH and AVP mRNA expression. Combined ADX + GDX inhibited only AVP, and testosterone and dihydrotestosterone (DHT) restored AVP mRNA. In the central nucleus of the amygdala, ADX decreased CRH mRNA expression, and this response was unaffected by GDX ± testosterone or DHT replacement. In the medial amygdala, AVP mRNA expression was decreased by ADX, abolished by ADX + GDX, and restored by androgen replacement. ADX had no effect on CRH and AVP mRNA expression in the BNST. GDX + ADX, however, reduced CRH mRNA expression only within the fusiform nuclei of the BNST and reduced the number of AVP‐expressing neurones in the posterior BNST. Androgen replacement reversed both responses. In summary, in ADX rats, AVP, but not CRH mRNA expression in the amygdala and mp PVN, is sensitive to GDX ± androgen replacement. Both CRH‐ and AVP‐expressing neurones in the BNST respond to GDX and androgen replacement, but not to ADX alone. Because androgen receptors are not expressed by hypophysiotropic PVN neurones, we conclude that glucocorticoid‐independent, androgenic influences on medial parvocellular AVP mRNA expression are mediated upstream from the PVN, and may involve AVP‐related pathways in the medial amygdala, relayed to and through CRH‐ and AVP‐expressing neurones of the BNST.